Risk Factors and A Prediction Model of Recurrence of Uterine Fibroids

Not yet recruitingOBSERVATIONAL

Enrollment

3,200

Participants

Timeline

Start Date

January 25, 2024

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2025

Conditions

Uterine FibroidRecurrence

Interventions

OTHER

No intervertion

This study is a retrospective observational study without intervention.

Trial Locations (1)

Shixuan Wang, Wuhan

All Listed Sponsors

collaborator

Tongji Hospital

OTHER

lead

Wenwen Wang

OTHER

NCT06234670 - Risk Factors and A Prediction Model of Recurrence of Uterine Fibroids | Biotech Hunter | Biotech Hunter